Hydrocephalus Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Hydrocephalus Market: By Type (Congenital Hydrocephalus and Acquired hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), Diagnosis Method (CT Scan, MRI, Head Ultrasound, and Others), Treatment (Surgery shunt insertion and Ventriculostomy), Age (Neonate & Pediatrics and Adults), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Hydrocephalus Market is expected to be valued at USD 7,340.4 million in 2022, growing at a 4.3% CAGR from 2022 to 2028. Hydrocephalus is a medical condition in which the cerebrospinal fluid (CSF) that generally passes through the spaces of the brain and spinal column in regular circumstances starts accumulating in the cavities of brain structures, resulting in a variety of cognitive abnormalities. Hydrocephalus in infants can be observed as head enlargement. The several symptoms of hydrocephalus are headaches, blurred vision, cognitive impairments, incontinence, and loss of coordination. A rise in the elderly age population and the increasing prevalence of neurological conditions are some major factors that drive the hydrocephalus market. Furthermore, rising healthcare expenditure also supports to propel the Hydrocephalus market growth. Hydrocephalus market growth could be restrained to a certain extent due to the rising number of product recalls dropping the demand for Hydrocephalus solutions. An upsurge in novel technological advancement will create lucrative opportunities among various prominent players in the market. Technological advancements are the primary trends gaining popularity in the hydrocephalus market. The prominent players in the market are developing technologically advanced hydrocephalus devices for the treatment of hydrocephalus.  For instance, In September 2019, Integra LifeSciences Holdings Corporation, a US-based medical device manufacturing company acquired Rebound Therapeutics for an undisclosed amount. Through this acquisition, Integra Lifescience will increase its collection of neurosurgical products and therapeutic-focused capabilities to develop more technologically innovative products to meet the neurosurgery needs of a wide range of patients. Moreover, the lack of accessibility in low and middle-income regions acts as a challenge for the Hydrocephalus market growth. The COVID-19 pandemic has affected numerous industrial sectors, and the Hydrocephalus market is had a negative impact due to the pandemic. The COVID-19 pandemic has disrupted the supply and demand of raw materials and finished products. However, with key players in the market investing in the advancement of hydrocephalic treatments, the market will further have a progressive growth rate during the forecasted period.

Recent Market Development:

In June 2021, Medtronic has announced the U.S. Food and Drug Administration (FDA) approval and the first U.S. implants of the SenSight Directional Lead System used for Deep Brain Stimulation (DBS) therapy. It will enhance their product sales in the neurological field.

in June 2021, Cranial Devices Inc., a US-based start-up from Pennsylvania State University advanced a device named HydroFix, a high-tech shunt system that involves a CSF drain to improve the treatment of hydrocephalus. HydroFix technology will address the significant unmet clinical needs of reducing the risks related to surgical shunts failure.

In June 2020, CereVasc raised $43.9 million in series A financing to support the development of a minimally invasive alternative for hydrocephalus.

Hydrocephalus Market

MARKET SUMMARY
-
4.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 4.3%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Hydrocephalus Market

  • The report on hydrocephalus market gives historical, current, and future market sizes (US$ Bn) on the basis of by type, diagnosis method, treatment and geography.
  • The hydrocephalus market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • DePuy Synthes
  • Boston Neurosciences
  • Medtronic Plc
  • Integra LifeSciences Corporation
  • Spiegelberg GmbH & Co. KG
Hydrocephalus Market Dynamics

Every day, the human body generates 500 ml of CSF, which is continuously replaced as it is absorbed. There is a balancing act between the volume of fluid generated and the pace at which it is absorbed by the body under normal circumstances. When this balance is upset, hydrocephalus develops. The most typical indirect treatment involves implanting a “shunt,” a medical device that directs extra CSF away from the brain. A shunt is a flexible tube that is inserted into the brain’s ventricle system to direct CSF flow to another area of the body where it may be absorbed. The increase in hydrocephalic patients, which in turn causes an increase in the number of shunting procedures performed globally, is one of the key reasons driving the growth of the hydrocephalus market. The Hydrocephalus Association estimates that in 2021, more than 36,000 shunt procedures will be done annually (one every 15 minutes), and more than half of them will be emergencies. Additionally, there is a strong need for hydrocephalic shunts due to the management of hydrocephalus and an increase in instances of neurological illnesses caused by congenital anomalies, lifestyle diseases, and incidents of brain and nerve injuries.


North-America Got Significant Share

Hydrocephalus Market

Due to the region's increased incidence of neurological disorders, rise in the total count of hydrocephalus patient populations, development of cutting-edge healthcare medical devices, and advancements in hydrocephalus technology, North America accounted for a significant portion of the global market for hydrocephalus in 2020 and is anticipated to maintain its dominance during the forecast period. However, Asia-Pacific is anticipated to experience the highest CAGR of 4.2% from 2022 to 2028. This is due to factors including a rise in the number of elderly people, who are more susceptible to neurological disorders, increasing attention to minimally invasive surgery, an increase in stroke and CSF-related illnesses, and technological innovations, which will help the hydrocephalus market grow faster than other regions during the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The hydrocephalus market report provides granular level information about the market size, regional market share and forecast from 2022-2028
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Hydrocephalus Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The hydrocephalus market is projected to expand at a CAGR of 3.5% during the forecast period

DePuy Synthes, Boston Neurosciences, Medtronic Plc, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc

North America is the fastest-growing region for hydrocephalus market


Report

Table Of Content

1. Executive Summary
2. Global Hydrocephalus Market Introduction
2.1. Global Hydrocephalus Market – Taxonomy
2.2. Global Hydrocephalus Market –Definitions
2.2.1. By Type
2.2.2. By Diagnosis Method
2.2.3. By Treatment
2.2.4. By Age
2.2.5. By Region
3. Global Hydrocephalus Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Hydrocephalus Market Dynamic Factors – Impact Analysis
3.6. Global Hydrocephalus Market – Competition Landscape
3.7. Number of Procedures
4. Global Hydrocephalus Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Hydrocephalus Market, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
5.1. Congenital Hydrocephalus
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Acquired hydrocephalus
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Normal-Pressure Hydrocephalus
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Ex-Vacuo Hydrocephalus
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Hydrocephalus Market Forecast, By Diagnosis Method, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. CT-Scan
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. MRI
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Head Ultrasound
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Hydrocephalus Market Forecast, By Treatment, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Surgery shunt insertion
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Ventriculostomy
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Hydrocephalus Market Forecast, By Age, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Neonate and Pediatrics
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Adults
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Hydrocephalus Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Hydrocephalus Market – Opportunity Analysis Index, By Type, By Diagnosis Method, By Treatment, By Age, and Region, 2022 – 2028
10. North America Hydrocephalus Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Congenital Hydrocephalus
10.1.2. Acquired hydrocephalus
10.1.3. Normal-Pressure Hydrocephalus
10.1.4. Ex-Vacuo Hydrocephalus
10.2. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. CT-Scan
10.2.2. MRI
10.2.3. Head Ultrasound
10.2.4. Others
10.3. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Surgery shunt insertion
10.3.2. Ventriculostomy
10.4. Age Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Neonate and Pediatrics
10.4.2. Adults
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Hydrocephalus Market – Opportunity Analysis Index, By Type, By Diagnosis Method, By Treatment, By Age, and Country, 2022 – 2028
10.7. North America Hydrocephalus Market Dynamics – Trends
11. Europe Hydrocephalus Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Congenital Hydrocephalus
11.1.2. Acquired hydrocephalus
11.1.3. Normal-Pressure Hydrocephalus
11.1.4. Ex-Vacuo Hydrocephalus
11.2. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. CT-Scan
11.2.2. MRI
11.2.3. Head Ultrasound
11.2.4. Others
11.3. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Surgery shunt insertion
11.3.2. Ventriculostomy
11.4. Age Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Neonate and Pediatrics
11.4.2. Adults
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Hydrocephalus Market – Opportunity Analysis Index, By Type, By Diagnosis Method, By Treatment, By Age, and Country, 2022 – 2028
11.7. Europe Hydrocephalus Market Dynamics – Trends
12. Asia-Pacific Hydrocephalus Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Congenital Hydrocephalus
12.1.2. Acquired hydrocephalus
12.1.3. Normal-Pressure Hydrocephalus
12.1.4. Ex-Vacuo Hydrocephalus
12.2. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. CT-Scan
12.2.2. MRI
12.2.3. Head Ultrasound
12.2.4. Others
12.3. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Surgery shunt insertion
12.3.2. Ventriculostomy
12.4. Age Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Neonate and Pediatrics
12.4.2. Adults
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Hydrocephalus Market – Opportunity Analysis Index, By Type, By Diagnosis Method, By Treatment, By Age, and Country, 2022 – 2028
12.7. Asia-Pacific Hydrocephalus Market Dynamics – Trends
13. Latin America Hydrocephalus Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
13.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Congenital Hydrocephalus
13.1.2. Acquired hydrocephalus
13.1.3. Normal-Pressure Hydrocephalus
13.1.4. Ex-Vacuo Hydrocephalus
13.2. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. CT-Scan
13.2.2. MRI
13.2.3. Head Ultrasound
13.2.4. Others
13.3. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Surgery shunt insertion
13.3.2. Ventriculostomy
13.4. Age Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Neonate and Pediatrics
13.4.2. Adults
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Hydrocephalus Market – Opportunity Analysis Index, By Type, By Diagnosis Method, By Treatment, By Age, and Country, 2022 – 2028
13.7. Latin America Hydrocephalus Market Dynamics – Trends
14. Middle East and Africa Hydrocephalus Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
14.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Congenital Hydrocephalus
14.1.2. Acquired hydrocephalus
14.1.3. Normal-Pressure Hydrocephalus
14.1.4. Ex-Vacuo Hydrocephalus
14.2. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. CT-Scan
14.2.2. MRI
14.2.3. Head Ultrasound
14.2.4. Others
14.3. Treatment Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Surgery shunt insertion
14.3.2. Ventriculostomy
14.4. Age Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Neonate and Pediatrics
14.4.2. Adults
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Hydrocephalus Market – Opportunity Analysis Index, By Type, By Diagnosis Method, By Treatment, By Age, and Country, 2022 – 2028
14.7. MEA Hydrocephalus Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. DePuy Synthes
15.2.2. Boston Neurosciences
15.2.3. Medtronic Plc
15.2.4. Integra LifeSciences Corporation
15.2.5. Spiegelberg GmbH & Co. KG
15.2.6. RAUMEDIC Inc
15.2.7. Sophysa SA
15.2.8. Terumo Corporation
15.2.9. Natus Medical Incorporated
15.2.10. Johnson & Johnson Services Inc
15.2.11. B. Braun Melsungen AG
15.2.12. Christoph Miethke GmbH & Co. KG
15.2.13. Tokibo Co. Ltd
15.2.14. HLL Lifecare Limited and others
16. Research Cause
17. Key Assumptions and Acronyms

Report

Company Profile

  • DePuy Synthes
  • Boston Neurosciences
  • Medtronic Plc
  • Integra LifeSciences Corporation
  • Spiegelberg GmbH & Co. KG
  • RAUMEDIC Inc
  • Sophysa SA
  • Terumo Corporation
  • Natus Medical Incorporated
  • Johnson & Johnson Services Inc
  • Braun Melsungen AG
  • Christoph Miethke GmbH & Co. KG
  • Tokibo Co. Ltd
  • HLL Lifecare Limited and others

Description

Hydrocephalus Market is expected to be valued at USD 7,340.4 million in 2022, growing at a 4.3% CAGR from 2022 to 2028. Hydrocephalus is a medical condition in which the cerebrospinal fluid (CSF) that generally passes through the spaces of the brain and spinal column in regular circumstances starts accumulating in the cavities of brain structures, resulting in a variety of cognitive abnormalities. Hydrocephalus in infants can be observed as head enlargement. The several symptoms of hydrocephalus are headaches, blurred vision, cognitive impairments, incontinence, and loss of coordination. A rise in the elderly age population and the increasing prevalence of neurological conditions are some major factors that drive the hydrocephalus market. Furthermore, rising healthcare expenditure also supports to propel the Hydrocephalus market growth. Hydrocephalus market growth could be restrained to a certain extent due to the rising number of product recalls dropping the demand for Hydrocephalus solutions. An upsurge in novel technological advancement will create lucrative opportunities among various prominent players in the market. Technological advancements are the primary trends gaining popularity in the hydrocephalus market. The prominent players in the market are developing technologically advanced hydrocephalus devices for the treatment of hydrocephalus.  For instance, In September 2019, Integra LifeSciences Holdings Corporation, a US-based medical device manufacturing company acquired Rebound Therapeutics for an undisclosed amount. Through this acquisition, Integra Lifescience will increase its collection of neurosurgical products and therapeutic-focused capabilities to develop more technologically innovative products to meet the neurosurgery needs of a wide range of patients. Moreover, the lack of accessibility in low and middle-income regions acts as a challenge for the Hydrocephalus market growth. The COVID-19 pandemic has affected numerous industrial sectors, and the Hydrocephalus market is had a negative impact due to the pandemic. The COVID-19 pandemic has disrupted the supply and demand of raw materials and finished products. However, with key players in the market investing in the advancement of hydrocephalic treatments, the market will further have a progressive growth rate during the forecasted period.

Recent Market Development:

In June 2021, Medtronic has announced the U.S. Food and Drug Administration (FDA) approval and the first U.S. implants of the SenSight Directional Lead System used for Deep Brain Stimulation (DBS) therapy. It will enhance their product sales in the neurological field.

in June 2021, Cranial Devices Inc., a US-based start-up from Pennsylvania State University advanced a device named HydroFix, a high-tech shunt system that involves a CSF drain to improve the treatment of hydrocephalus. HydroFix technology will address the significant unmet clinical needs of reducing the risks related to surgical shunts failure.

In June 2020, CereVasc raised $43.9 million in series A financing to support the development of a minimally invasive alternative for hydrocephalus.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX